Additional manufacturer narrative: the device was not returned to edwards for evaluation as healthcare provider reported it was discarded.The device history record (dhr) was not reviewed as the reported event does not allege a malfunction that could be related to a manufacturing deficiency and/or one was not confirmed through investigation.Post-operatively, the body undergoes various phases of the tissue response continuum resulting in the fibrous encapsulation of the ring.Local and systemic factors of the patient may play a role in the wound healing and inflammatory responses to biomaterials and implants.Based on the information received the cause cannot be determined; however, patient factors may have contributed to the event.Edwards will continue to review and monitor all events.Trends are monitored on a monthly basis and if action is required, appropriate investigation will be performed.
|
Edwards lifesciences maintains an implant patient registry.This registry is a patient tracking mechanism for serialized edwards implantable devices (bioprosthetic heart valves and annuloplasty rings), rather than a true post-market surveillance registry.Through the registry, edwards is notified when these devices are implanted.In addition, patient and/or device status may be reported to the registry via the implantation data cards.The information is received from various sources (e.G.Surgeon, hospital, and patient family members) and is not received in the form of a conventional "customer complaint." the information reported may or may not be related to the edwards device.In this case, edwards learned a 32mm mitral ring was explanted after an implant duration of two years, one month, due to severe mitral regurgitation, mitral valve prolapse, and moderate stenosis.At explant of the 32mm ring it was noted there was severe fibrosis thickening related to the annuloplasty ring."there was also very severe pericardial reaction suggesting probable rheumatic pericarditis." the explanted device was replaced with a 27mm mitral valve.The patient tolerated the procedure well.Patient is status seven on the heart transplant list.Patient was discharged on post operative day 14.
|